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Differentiation of 3T3-L1 cells into adipocytes involves a highly orchestrated series of complex
events in which microRNAs might play an essential role. In this study, we found that the overexpres-
sion of microRNA-344 (miR-344) inhibits 3T3-L1 cell differentiation and decreases triglyceride accu-
mulation after MDI stimulation. We demonstrated that miR-344 directly targets the 30 UTR of GSK3b
(Glycogen synthase kinase 3 beta). Knockdown of GSK3b with siRNA results in inhibiting 3T3-L1 dif-
ferentiation, while its overexpression restores the effect of miR-344. In addition, miR-344 elevates
the level of active b-catenin, which is the downstream effector of GSK3b in the Wnt/b-catenin signal-
ing pathway. These data indicate that miR-344 inhibits adipocyte differentiation via targeting GSK3b
and subsequently activating the Wnt/b-catenin signaling pathway.
Crown Copyright  2013 Published by Elsevier B.V. on behalf of Federation of European Biochemical
Society. All rights reserved.1. Introduction
Obesity is a prevalent health issue in developed countries and is
usually associated with plenty of pathological disorders, including
diabetes, hyperglycemia, hyperlipidemia, atherosclerosis and chronic
inﬂammation [1,2]. In terms with this wide range of health hazard,
the necessary to develop new and effective strategies in controlling
obesity has become more acute. Obesity is the result of increase in
the adipocyte numbers and in the adipocyte size. Mature adipocytes
arise from preadipocytes and progenitor cells, which reside in adi-
pose tissue. Preadipocytes and progenitors undergo a terminal differ-
entiation process into mature adipocytes. Therefore, controlling this
process could ameliorate obesity and obesity related syndrome.
MicroRNAs (miRNAs) are endogenous noncoding RNAs
comprising 18–25 base pairs. miRNAs can modify gene expression
at the post-transcriptional level by complementing to the 30 untrans-
lated region (UTR) of its target gene, and mediating mRNA degrada-
tion or translation inhibition [3]. miRNAs have been conﬁrmed to
beplayed crucial roles in diverse biological processes, including pro-
liferation, differentiation, development, apoptosis, immunity, and
oncogenesis [4–7]. miRNAs have also been shown to participate in
adipocyte differentiation in mice, pigs, and humans [8–11].Previously, the high throughput microarray assays found that
miR-344 was remarkably up-regulated in 3T3-L1 cells after LiCl
treatment [12]. In line with the results of microarray assays,
miR-344 was up-regulated in adipogenesis after LiCl stimulation.
However, our research found that miR-344 down-regulated signif-
icantly during adipogenesis under normal culture conditions, sug-
gesting that miR-344 plays a role in adipocyte differentiation. It is
possible that miR-344 might affect adipocyte differentiation. As we
known, Wnt/b-catenin signaling pathway can be activated by LiCl
and subsequently inhibit adipogenesis [13,14]. Therefore, we
hypothesis that miR-344 might regulate adipogenesis through
activating Wnt/b-catenin signaling pathway.
In this study, we demonstrated that overexpressingmiR-344 could
inhibit 3T3-L1 preadipocyte differentiation into adipocyte. GSK3b, the
key component of Wnt/b-catenin signaling, was conﬁrmed to be the
target of miR-344, and knockdown of endogenous GSK3b by siRNA
could inhibit 3T3-L1 preadipocyte differentiation. In addition, miR-
344 could increase active b-catenin, which is the downstream effec-
tor of GSK3b and able to activate the transcription of genes that re-
pressed preadipocyte differentiation. These results revealed a
mechanism of miR-344 in regulating 3T3-L1 cells differentiation.
2. Materials and methods
2.1. Cell culture and transfection
Mouse 3T3-L1 cell line and human embryonic kidney (HEK)
293T cell line were purchased from the American Type Culture
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430 H. Chen et al. / FEBS Letters 588 (2014) 429–435Collection (ATCC). The cell lines were maintained in Dulbecco
modiﬁed Eagle medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), and antibiotics (100 U/mL penicillin and
100 lg/L streptomycin) at 37 C in the 5% CO2, humidiﬁed atmo-
sphere. 3T3-L1 and HEK 293T cells were transfected with plasmid
DNA, miRNA mimics (RIBOBIO, Guangzhou, China) and siRNA
(RIBOBIO) by using Lipofectamine™ 2000 (Invitrogen, Shanghai,
China) according to the manufacturer’s instruction.
2.2. 3T3-L1 induction differentiation
Adipogenic differentiation was carried out according to previ-
ously published protocol. 3T3-L1 preadipocytes were grown to
conﬂuence, 2 days later, 3T3-L1 were stimulated for 3 days in dif-
ferentiation medium: DMEM containing 10% FBS and MDI
(10 lg/mL insulin, 1 lM dexamethasone, and 0.5 mM IBMX). Cells
were then maintained in DMEM containing 10% FBS and 10 lg/mL
insulin. The medium was replaced every other day. Mature adipo-
cytes were visualized by staining with Oil Red O solution.
2.3. Oil red O staining
Cellswerewashedwith PBS andﬁxedwith 4%paraformaldehyde
for 10 min. For Oil Red O quantitative analysis, the intracellular ab-
sorbedOil RedOwas extracted in 100% isopropanol, and absorbance
was measured at 510 nm wave length.
2.4. Plasmid construction
For GSK3b 30 UTR reporter assay, the potential binding sites se-
quence were obtained by annealing sense and antisense strand
(Table 1), and then the annealed sequences were inserted down-
stream of the stop codon of Renilla luciferase gene in psiCHECK-2
dual-luciferase reporter plasmid (Promega, Madison, USA), desig-
nated as psiCHE-GSK3b 30 UTR-wt. psiCHE-GSK3b 30 UTR-mut,
which carried a mutated sequence in the putative binding site
for miR-344, was generated by randomly disorganized seed region
of annealed sequences.
To construct GSK3b overexpression vector (3.1-GSK3b), GSK3b
coding sequence was ampliﬁed by PCR (primers in Table 1) and
then cloned into NheI and XhoI site in pcDNA3.1 vector
(Invitrogen).
2.5. Luciferase reporter assay
HEK 293T cells were plated in 48-well plates at a density of
6  104 cells per well. Cells were transfected with 50 ng
psiCHECK-2 recombination vector and miR-344 mimics or miRNA
mimics Negative Control. Four replicates were made for each
transfection. Fireﬂy and Renilla luciferase activities were measured
with the Dual-Glo luciferase system (Promega) and measured with
SynergyTM 2 multi-mode readers (BioTek, Vermont, USA) at
48 hours after transfection.
2.6. RNA isolation and qPCR
Total RNA was extracted using TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. First-strand cDNA
was obtained using the Reverse Transcription System (Promega),
Oligo(dT) and Stem-loop Reverse Transcription primer for mRNA
and miRNA, respectively. Quantitative real-time PCR (qPCR) was
performed using SYBR Premier Dimer Eraser™ (TaKaRa, Dalian, Chi-
na) on a LightCycler 480 (Roche, Basel, Switzerland), and relative
quantiﬁcation (244Ct) method was used to analyze the data.
Endogenous NoNomRNAwas used as reference for mRNA quantiﬁ-
cation, as it was expressed stable in murine [15], and U6 for miRNA.
H. Chen et al. / FEBS Letters 588 (2014) 429–435 4312.7. Western blot
Cellswere lysed in cell lysis buffer (Beyotime, Shanghai, China) in
the presence of a protease inhibitor cocktail (Sigma, Shanghai, Chi-
na) and phosphatase inhibitors (5 mM Na4P2O7, 50 mM NaF, 1 mM
vanadate), and protein content was quantiﬁed by BCA methods
[16]. 40 lg total cellular protein was fractionated by 12% (w/v)
SDS–PAGE and electronically transferred to 0.45 lm PVDF
membrane (Roche). The membrane was blocked for 2 hours in
TBS-Tween20 (TBST) containing 5% (w/v) skimmed milk, and
incubated with primary antibody for 1 hour at room temperature.
The membrane was washed with TBST and incubated for 1 hour
with secondary antibody. Blots were visualized using a commercial
enhanced chemiluminescene (ECL) detection Kit (Thermo Scientiﬁc,
Guangzhou, China). GSK3b was measured by monoclonal anti-
GSK3b antibody (#9315, CST, Shanghai, China). Active b-catenin
(non-phosphorylation) was detected by monoclonal anti-
Non-phospho b-catenin antibody (Ser33/37/Thr41) (#8814, CST).
Monoclonal anti-b-catenin antibody (#8480, CST) was used to de-
tect total b-catenin protein. Cyclin D1 was detected by monoclonal
Cyclin D1 antibody (#2926, CST). GAPDH protein was used as
reference (sc-59540, Santa Cruz Biotechnology, Shanghai, China),
and the secondary antibody was HRP-conjugated goat anti-rabbit
IgG (#7074s, CST) and HRP-conjugated goat anti-mouse IgG
(#7076s, CST).
2.8. Statistical analysis
All results are presented as mean ± standard errors of the means
(SEM) based on at least three separate experiments. Unless other-
wise noted, the differences between groups were analyzed by
using a Student’s two-tailed t test when only two groups were
compared or by ANOVA when more than two groups were com-
pared. Differences were regarded as signiﬁcant at a P value of
<0.05.Fig. 1. Up-regulation of miR-344 in LiCl stimulated 3T3-L1 cells. (A) 3T3-L1 preadipocyte
was initiated after 48 hours treatment. Cells were ﬁxed and stained with Oil Red O on day
measured the absorbance at 510 nm wave length. (C) miR-344 was detected during 3
treatment by using Stem-loop qPCR. Data are means of at least three independent expe3. Results
3.1. miR-344 was signiﬁcantly up-regulated during 3T3-L1 cells
differentiation after LiCl treatment
The preadipocytes which treated with LiCl failed to differentiate
into mature adipocytes after MDI stimulation, as conﬁrmed by Oil
Red O staining and quantitative analysis (Fig. 1A and B). As a
control, NaCl was used in place of LiCl before MDI stimulation,
the preadipocytes differentiated normally into adipocytes. To
determine the changes of miR-344 during 3T3-L1 cells differentia-
tion, cells were collected at different time points, including 1 day
(1D), 0D (MDI stimulation), 6 hour (H), 12H, 1D, 2D, 4D, and 6D.
Stem-loop qPCR results showed that miR-344 was signiﬁcantly
down-regulated after MDI stimulation on 0D under normal culture
conditions, and maintained low level in adipogenesis (Fig. 1C).
However, Compared with NaCl group, miR-344 was markedly
up-regulated on 1D, 12H, 1D and 2D after LiCl treatment
(Fig. 1D). In addition, the expression of miR-344 also increased
on 0D, 6H, 4D, 6D, although these differences did not reach statis-
tical signiﬁcance (Fig. 1D). These results indicated that miR-344
might inhibit 3T3-L1 preadipocyte differentiation.
3.2. miR-344 repressed 3T3-L1 preadipocytes differentiation
To investigate the role of miR-344 in adipogenesis, 3T3-L1 pre-
adipocytes were transfected with miR-344 mimics or miRNA mim-
ics Negative Control (NC) before adipogenic stimulation. Using
stem-loop qPCR assay, it was found that a 400-fold increase for
mature miR-344 in the transfected preadipocytes (P < 0.01)
(Fig. 2C). As shown in Fig. 2A, miR-344 strongly inhibited 3T3-L1
preadipocytes differentiating into mature adipocytes, as demon-
strated by a reduction of the number of Oil Red O positive cells.
In contrast, the irrelevant Negative Control did not affect
adipogenic differentiation. Quantitative analysis of intracellulars were grown to conﬂuence and treated with LiCl or NaCl, adipogenic differentiation
6 after MDI stimulation; (B) quantiﬁed lip accumulation by extracting Oil Red O and
T3-L1 cells differentiation under normal culture conditions, and (D) LiCl or NaCl
riments; error bars indicate SEM. ⁄P < 0.05; ⁄⁄P < 0.01.
432 H. Chen et al. / FEBS Letters 588 (2014) 429–435accumulation neutral lipids revealed statistically signiﬁcant
inhibition of adipocyte formation (P < 0.01) (Fig. 2B). Several
well-deﬁned key transcription factors of adipogenic differentiation
were also detected during differentiation by qPCR. Compared with
Negative Control group, the expression of PPARc, C/EBPa, FABP4
and Adiponectin genes were signiﬁcantly down-regulated in cells
transfected with miR-344 mimics (Fig. 2D–G). Collectively, theseFig. 2. miR-344 inhibited 3T3-L1 preadipocytes differentiation. (A) 3T3-L1 preadipocy
(50 nM) and NC (50 nM), adipogenic differentiation was initiated at 24 hours post-transfe
quantiﬁed lip accumulation by extracting Oil Red O and measured the absorbance at 510
were induced to undergo differentiation. After 24 hours post-transfection, miR-344 transf
CEBPa, FABP4 and Adiponectin at 1D, 0D, 2D, 4D, 8D, and 10D after MDI stimulation. D
⁄P < 0.05; ⁄⁄P < 0.01.
Fig. 3. GSK3b was a direct target of miR-344. (A) The predicted binding site of miR-344
reporter vector psi-CHECK2 at the 30 end of hRluc (Renilla luciferase gene), the consti
psiCHECK2, psiCHE-GSK3b 30 UTR wt or psiCHE-GSK3b 30 UTRmut vector was co-transfec
was determined. (C) GSK3b mRNA measured by qPCR, and (D) protein expression d
preadipocytes at 72 hours post-transfection with miR-344 mimics. Data are means of atresults showed that miR-344 could inhibit 3T3-L1 preadipocyte
differentiation.
3.3. miR-344 directly targeted 30 UTR of GSK3b
In order to reveal the mechanisms by which miR-344 sup-
presses 3T3-L1 preadipocyte differentiation, we focused initiallytes were grown to conﬂuence and transiently transfected with miR-344 mimics
ction. Cells were ﬁxed and stained with Oil Red O on day 6 after MDI stimulation; (B)
nm wave length. (C) 3T3-L1 preadipocytes transfected with miR-344 mimics or NC
ection efﬁciency was determined by stem-loop qPCR. (D) And qPCR analyzed PPARc,
ata are means of at least three independent experiments; error bars indicate SEM.
in the 30 UTR of GSK3b (up). The GSK3b 30 UTR was inserted into the dual-luciferase
tutive ﬁreﬂy luciferase (hluc+) was used as an internal control (bottom). (B) The
ted with miR-344 or NC into HEK293 cells, and normalized Renilla luciferase activity
etected by western blotting (up) and densitometry analysis (bottom) in 3T3-L1
least three independent experiments; error bars indicate SEM. ⁄P < 0.05; ⁄⁄P < 0.01.
H. Chen et al. / FEBS Letters 588 (2014) 429–435 433on identifying the potential targets of miR-344. The genes involved
in Wnt/b-catenin signaling pathway got more attention, because
miR-344 was up-regulated after LiCl treatment, furthermore, LiCl
is able to activate Wnt/b-catenin signaling pathway which inhibits
adipogenesis. Consequently, GSK3b, a key component of Wnt sig-
naling pathway, was predicted by TargetScan (http://www.target-
scan.org), RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/
rnahybird/), and miRanda (http://www.microrna.org/microrna/
getGeneForm.do) analysis as a prime target (Fig. 3A, up).
To conﬁrm mouse GSK3b as a target of miR-344 actually, we
synthetized sequences of wild-type 30 UTR of mouse GSK3b con-
taining putative binding site for miR-344 and the mutant 30 UTR
with a 7 bp mutation in the seed region. After anneal, the se-
quences were inserted downstream of the luciferase gene
(Fig. 3A, bottom) and luciferase assays were performed in HEK
293T cells. As shown in Fig. 3B, compared with Negative Control
group, co-transfection of miR-344 mimics with the mouse GSK3b
30 UTR wild-type reporter (psiCHE-GSK3b 30 UTR-wt) resulted in
a highly signiﬁcant decrease in luciferase activity (P < 0.05). Con-
sistent with the result, no decrease in luciferase activity was ob-
served when miR-344 mimics or Negative Control co-transfected
with the empty vector or the mutant reporter (psiCHE-GSK3b 30
UTR-mut), indicating that the predicted site is a direct target of
miR-344.Fig. 4. Overexpression GSK3b could restore the effect of miR-344. (A) Transfection of t
GSK3b mRNA (left) and protein (right), detected by qPCR and western blotting, (B) wh
quantitation). (C) Overexpression of GSK3b through transfection of GSK3b expression ve
levels was detected. (D) 3T3-L1 preadipocytes were grown to conﬂuence, co-transfected
pcDNA3.1; adipogenic differentiation was initiated at 24 hours post-transfection. Cell
quantitative analysis Oil Red O (right). (E) qPCR analysis mRNA expression of PPARc, C
post-transfection with miR-344 mimics into 3T3-L1 preadipocytes, qPCR analysis b-cate
b-catenin) and Cyclin D1 protein levels (middle), and the differences were analyzed by
error bars indicate SEM. ⁄P < 0.05; ⁄⁄P < 0.01.To examine whether the miR-344 can regulate the expression of
GSK3b or not, GSK3b mRNA and protein level were measured in
3T3-L1 cells transiently transfected with miR-344 mimics by qPCR
and western blotting, respectively. As a result, miR-344 inhibited
endogenous GSK3b protein expression in 3T3-L1 preadipocytes
(Fig. 3D), even though no signiﬁcant inhibition was detected at
the mRNA level (Fig. 3C). Taken together, these results indicate that
GSK3b is a direct and authentic target of miR-344.
3.4. miR-344 suppressed adipogenesis through targeting GSK3b and
activating Wnt/b-catenin signaling pathway
GSK3bwas shown to be an authentic target of miR-344, but fur-
ther investigation was needed to determine whether miR-344
inhibited 3T3-L1 differentiation through direct down-regulation
GSK3b. Firstly, we investigated whether reducing GSK3b expres-
sion might resemble the repression effect of miR-344 overexpres-
sion. After transfection of siGSK3b into 3T3-L1 preadipocytes, it
was not only substantially knocked down the expression of GSK3b
mRNA and protein (Fig. 4A), but also resulted in signiﬁcantly
suppression of 3T3-L1 preadipocytes differentiation (Fig. 4B). This
result is in line with the inﬂuence of GSK3b inhibitors, which can
suppress GSK3b protein expression and impair the adipocyte dif-
ferentiation [17–19]. Thus, disruption of GSK3b inhibited 3T3-L1hree different siGSK3b into 3T3-L1 preadipocytes to knockdown the expression of
ich resulted in suppressed differentiation of 3T3-L1 cells (Oil Red O staining and
ctor (3.1-GSK3b) into 3T3-L1 preadipocytes, GSK3b mRNA (left) and protein (right)
with miR-344 and 3.1-GSK3b, NC and pcDNA3.1, NC and 3.1-GSK3b, miR-344 and
s were ﬁxed and stained with Oil Red O on day 6 after MDI stimulation, then
EBPa, FABP4 and Adiponectin from corresponding transfections. (F) After 72 hours
nin mRNA level (left), western blotting detected b-catenin, active b-catenin (Non-P
densitometry analysis. Data are means of at least three independent experiments;
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434 H. Chen et al. / FEBS Letters 588 (2014) 429–435preadipocytes differentiation, similar to the result of miR-344
overexpression.
Furthermore, we examined whether constitutive expression of
GSK3b could counteract the repression effect of miR-344. Overex-
pression of GSK3b by transfecting 3.1-GSK3b, as evidenced by
raised expression of GSK3b mRNA and protein (Fig. 4C), resulted
in no apparent change in 3T3-L1 cells differentiation efﬁciency
(Fig. 4D, 3.1-GSK3b + NC vs. pcDNA3.1 + NC). However, GSK3b
was conﬁrmed to be a target of miR-344 during adipocyte differen-
tiation, its role was further assessed by its overexpression in
3T3-L1 preadipocytes in the presence of transfected miR-344,
which increased 3T3-L1 cells differentiation efﬁciency (Fig. 4D,
3.1-GSK3b+miR-344). As expected, the presence of miR-344 with
control empty plasmid (pcDNA3.1) in 3T3-L1 preadipocytes led
to suppression of 3T3-L1 cells differentiation (Fig. 4D). Further-
more, the decrease in adipogenic marker gene expression (PPARc,
CEBPa, FABP4 and Adiponectin) as a result of miR-344 transfection
was attenuated by co-expression of GSK3b (Fig. 4E). Therefore, the
overexpression of GSK3b could restore adipocytes differentiation
and overcome the effect of miR-344.
In addition, b-catenin, the substrate of GSK3b in Wnt/b-catenin
signaling, mRNA level was notably augmented (P < 0.01 ) after
transfected with miR-344 mimics (Fig. 4F, left). Although the pro-
tein level of b-catenin was increased, the difference did not reach
statistical signiﬁcance (P = 0.287) (Fig. 4F middle and right). To
the best of our knowledge, GSK3b modulated b-catenin through
phosphorylating it at Thr-41, Ser-37 and Ser-33 [20]. So we
detected the active b-catenin (non-phosphorylation) by anti-Non-
phospho b-catenin (Ser33/37/Thr41). In a marked contrast, the
active b-catenin was signiﬁcantly increased (P < 0.01) while
miR-344 overexpression (Fig. 4F, middle and right). Generally,
large amounts of b-catenin in cytoplasm might translocate into
the nucleus, and then stimulate b-catenin-dependent genes
transcription which participated in inhibiting adipogenic genes
expression. Furthermore, we found that Cyclin D1, a well-known
target of b-catenin, was appreciably up-regulated (P < 0.01) when
active b-catenin increased (Fig. 4F, middle and right). Collectively,miR-344 inhibited GSK3b protein translation and increased
b-catenin level, and the latter might translocate into nucleus and
activate the transcription of genes that repressed adipocytes
differentiation.
4. Discussion
In recent years, a number of miRNAs have been found as a class
of modulator in gene expression regulation through altering mRNA
or translation level [3]. Many studies have shown that miRNAsmay
function as either pro-adipogenesis or anti-adipogenesis genes.
miR-344 was ﬁrst isolated from rat embryonic primary cortical
neurons [21]. In mouse, miR-344 encoding gene located nearby
the mouse 7C imprinted domains, strongly suggesting an
imprinted expression [22]. However, the function of miR-344 is
unclear so far. Our previous research implicated miR-344 might in-
volve in regulating adipocyte differentiation [12]. In this study, we
demonstrated that miR-344 inhibit 3T3-L1 preadipocyte differenti-
ation through down-regulating the expression of GSK3b by target-
ing the 30 UTR of GSK3b (Fig. 3B and D).
GSK3b is a serine/threonine kinase that originally identiﬁed as a
regulator of cell metabolism but participated in a number of
bioprocesses, for instance, protein synthesis, cell proliferation, cell
differentiation, microtubule dynamics and cell motility by phos-
phorylating initiation factors [23]. DisruptionGSK3bprotein expres-
sion by GSK3b inhibitors (i.e. LiCl, BIO [17], and SB415286 [18])
could inhibited preadipocyte differentiation. Presently, we demon-
strated that knockdownGSK3b could suppress 3T3-L1 preadipocyte
differentiation (Fig. 4B). Conversely, overexpression GSK3b can
counteract the inhibition effect of miR-344 on adipocyte differenti-
ation (Fig. 4D). In fact, GSK3b is a key component of Wnt/b-catenin
signaling pathway. GSK3b destabilizes b-catenin, which is a key
downstream effector in theWnt/b-catenin signaling, by phosphory-
lating it at Thr-41, Ser-37 and Ser-33. Then phosphorylated
b-catenin can be recognized by E3 ubiquitin ligase, this cause
b-catenin to be degraded by the proteasome thus the transcriptional
targets of b-catenin remain off. Conversely, decreasing GSK3b could
H. Chen et al. / FEBS Letters 588 (2014) 429–435 435facilitate the accumulation of b-catenin in cytoplasm [14]. We
showed here that miR-344 decreased GSK3b protein expression
(Fig. 3D), and elevated active b-catenin (Non-P b-catenin) (Fig. 4F).
This allows b-catenin to accumulate in cytoplasm and enter the nu-
cleus, where it stimulates the transcription of b-catenin-dependent
genes that result in decrease of adipogenic genes expression. As we
know, CyclinD1was awell-knownb-catenin target gene [24]. Farm-
er group found that augmented b-catenin level increased Cyclin D1
[25], which can inhibit PPARc-mediated adipogenesis [26,27]. The
regulatory mechanism of miR-344 can be illuminated in the model
(Fig. 5).
In conclusion, our study has proved the fundamental role and
mechanism of miR-344 in the suppression of adipocyte differenti-
ation, at least in part, by inhibiting GSK3b at the post-transcrip-
tional level and activating the transcription of the Wnt/b-catenin
signaling pathway downstream genes that decrease the expression
of adipogenic genes. Therefore, miR-344 and its target genes may
potentially play a role in the pathological progression of obesity-
related diseases.
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